Emodin accelerates osteoblast differentiation through phosphatidylinositol 3-kinase activation and bone morphogenetic protein-2 gene expression
- PMID: 18387517
- DOI: 10.1016/j.intimp.2008.01.027
Emodin accelerates osteoblast differentiation through phosphatidylinositol 3-kinase activation and bone morphogenetic protein-2 gene expression
Abstract
Emodin is a naturally occurring anthraquinone present in the roots and bark of numerous plants of the genus Rhamnus. Here, we identified emodin as one of compounds activating the mRNA expression of bone morphogenetic protein (BMP)-2 in the differentiation process of mouse osteoblastic MC3T3-E1 subclone 4 cells. Without any effect on cell growth, the low concentration (up to 5 microM) of emodin highly induced the mRNA expression of BMP-2, the expression of alkaline phosphatase (an early marker of osteoblast differentiation), and the mineralization. Interestingly, emodin induced the activation of phosphatidylinositol 3-kinase (PI3K), Akt and mitogen-activated protein (MAP) kinases, but those inductions by emodin were completely inhibited by the PI3K inhibitor, LY294002, suggesting that the up-regulation of BMP-2 by emodin could be mediated through the activation of both Akt and MAP kinases by activating PI3K. Additionally, emodin-induced activation of NF-kappaB suggested that NF-kappaB might be required for its anabolic activity in part. In conclusion, the use of natural compounds with anabolic activity such as emodin could have a beneficial effect on bone health and this kind of studies further elucidate the pharmacological roles of natural compounds in the prevention of osteoporosis and provide the initiative in the early drug discovery and development for osteoporosis.
Similar articles
-
Physcion-8-O-beta-D-glucopyranoside enhances the commitment of mouse mesenchymal progenitors into osteoblasts and their differentiation: Possible involvement of signaling pathways to activate BMP gene expression.J Cell Biochem. 2010 Apr 15;109(6):1148-57. doi: 10.1002/jcb.22494. J Cell Biochem. 2010. PMID: 20108254
-
Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation.J Bone Miner Res. 2003 Nov;18(11):2060-8. doi: 10.1359/jbmr.2003.18.11.2060. J Bone Miner Res. 2003. PMID: 14606520
-
Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.J Bone Miner Res. 2014 Jul;29(7):1541-53. doi: 10.1002/jbmr.2183. J Bone Miner Res. 2014. PMID: 25832436
-
Exploring the journey of emodin as a potential neuroprotective agent: Novel therapeutic insights with molecular mechanism of action.Biomed Pharmacother. 2022 May;149:112877. doi: 10.1016/j.biopha.2022.112877. Epub 2022 Mar 31. Biomed Pharmacother. 2022. PMID: 35367766 Review.
-
Is Emodin with Anticancer Effects Completely Innocent? Two Sides of the Coin.Cancers (Basel). 2021 May 31;13(11):2733. doi: 10.3390/cancers13112733. Cancers (Basel). 2021. PMID: 34073059 Free PMC article. Review.
Cited by
-
Safety of natural anthraquinone emodin: an assessment in mice.BMC Pharmacol Toxicol. 2021 Jan 28;22(1):9. doi: 10.1186/s40360-021-00474-1. BMC Pharmacol Toxicol. 2021. PMID: 33509280 Free PMC article.
-
Effects of emodin on inflammatory bowel disease-related osteoporosis.Biosci Rep. 2020 Jan 31;40(1):BSR20192317. doi: 10.1042/BSR20192317. Biosci Rep. 2020. PMID: 31934719 Free PMC article.
-
Inhibition of mechanical stress-induced hypertrophic scar inflammation by emodin.Mol Med Rep. 2015 Jun;11(6):4087-92. doi: 10.3892/mmr.2015.3265. Epub 2015 Jan 28. Mol Med Rep. 2015. PMID: 25634255 Free PMC article.
-
The bone-protective mechanisms of active components from TCM drugs in rheumatoid arthritis treatment.Front Pharmacol. 2022 Oct 25;13:1000865. doi: 10.3389/fphar.2022.1000865. eCollection 2022. Front Pharmacol. 2022. PMID: 36386147 Free PMC article. Review.
-
High water-soluble curcuminoids-rich extract regulates osteogenic differentiation of MC3T3-E1 cells: Involvement of Wnt/β-catenin and BMP signaling pathway.Chin Herb Med. 2021 Jan 26;13(4):534-540. doi: 10.1016/j.chmed.2021.01.003. eCollection 2021 Oct. Chin Herb Med. 2021. PMID: 36119369 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
